FundedIQ

Recently Funded Biotechnology Startups in Palo Alto

Updated Sep 2026

There are 31 funded Biotechnology startups in Palo Alto in the FundedIQ database, each with its funding rounds, amounts, investors, industries, locations and company details. This page provides an overview of the Biotechnology startup funding landscape in Palo Alto, along with the 31 most recently funded Biotechnology startups in Palo Alto.

The median disclosed round is $26M, with the middle half of rounds falling between $8.0M and $43M. Biotechnology startups in Palo Alto closed 18 funding rounds over the last 24 months, 9 of them in the last 12 months, and raised $1.2B in disclosed capital.

Palo Alto biotechnology firms cluster as mid-sized teams with a smaller group of early stage ventures. These companies possess enough staff to maintain internal operations but remain small enough for direct access to leadership. This profile favors vendors selling scalable infrastructure or specialized laboratory equipment to growing organizations.

Biotechnology funded startup statistics in Palo Alto

Funded Biotechnology startups in Palo Alto
31
tracked in the database
Funding rounds, last 12 months
9
18 over 24 months
Disclosed capital raised, 24 months
$1.2B
15 of 18 rounds disclosed an amount
Median round size
$26M
middle half $8.0M to $43M

Most recent funding round on record: Jun 2026.

31 most recently funded Biotechnology startups in Palo Alto

31 shown

Ordered by the date of the latest funding round. Each row gives the company, its location and industry, what it does, the stage and date of that round, and the disclosed amount.

S
Palo Alto, United States · Biotechnology
Spot BioSystems is a bioengineering firm that specializes in personalized cancer treatments. The company's…
Series Unknown ·
$40M
C
Palo Alto, United States · Biotechnology
Countable Labs provides a PCR system for single-molecule counting and high-sensitivity molecular detection in…
Series Unknown ·
$26M
P
Palo Alto, United States · Biotechnology
Pumpkinseed allows for high-speed readings of biological bits.
Series A ·
$20M
A
Palo Alto, United States · Biotechnology
Avenue Biosciences is a biotechnology company dedicated to accelerating the discovery and development of…
Seed ·
$7.4M
J
Palo Alto, United States · Biotechnology
Juvena Therapeutics is a startup in the biopharmaceutical industry that has received funding and is…
Series B ·
$34M
U
Palo Alto, United States · Biotechnology
Ukko is a biotech firm focused on creating safe immunotherapies for quickly addressing allergies and other…
Series C ·
$45M
K
Palo Alto, United States · Biotechnology
Kodiak Sciences is designing and developing novel therapies for the treatment of retinal disease. As a…
Series Unknown ·
$184M
M
Palo Alto, United States · Biotechnology
Myome distinguishes qualities that cause sickness and act in light of driving science. The information is…
Series Unknown ·
Undisclosed
E
Palo Alto, United States · Biotechnology
EpaleX is developing a novel inhaled treatment for epilepsy and migraine. The treatment for the first time…
Venture - Series Unknown ·
$1.2M
B
Palo Alto, United States · Biotechnology
BBOT is a biopharmaceutical company in the clinical stage that is developing a new pipeline of small molecule…
Series Unknown ·
$261M
B
Palo Alto, United States · Biotechnology
Biostate AI aims to create generative AI that can positively impact human health. We recognize that…
Series A ·
$12M
H
HepaTx
Palo Alto, United States · Biotechnology
Our vision is to provide regenerative medicine treatments that free patients from chronic liver disease and…
Series Unknown ·
Undisclosed
B
Palo Alto, United States · Biotechnology
BridgeBio is a biotechnology company that focuses on genetic disease therapies and develops those assets with…
Series Unknown ·
$500M
I
Palo Alto, United States · Biotechnology
I Peace is a cell and gene therapy CDMO specializing in iPSC-derived cell products. We provide cGMP…
Series Unknown ·
$8.5M
O
Palo Alto, United States · Biotechnology
OrsoBio is a company that develops treatments for patients with serious metabolic disorders like diabetes,…
Series B ·
$67M
A
Amygdala Neuroscience
Palo Alto, United States · Biotechnology
Amygdala Neurosciences is working on creating a new medication called ANS-6637 to treat substance use…
Series Unknown ·
Undisclosed
D
DigPath
Palo Alto, United States · Biotechnology
We are an innovative AI-driven digital pathology company, dedicated to shaping the future of diagnostics and…
Series Unknown ·
Undisclosed
F
Palo Alto, United States · Biotechnology
Forest Neurotech is developing a novel BCI using ultrasound technology that can detect and alter the entire…
·
$14M
I
Palo Alto, United States · Biotechnology
ImpriMed offers advanced personalized medicine that is conveniently available for pets suffering from blood…
Series A ·
$23M
L
Palo Alto, United States · Biotechnology
Proactive & data-driven Compliance Platform for Pharma
Series A ·
$7.0M
G
Palo Alto, United States · Biotechnology
Greenstone Biosciences is a drug discovery platform that accelerates the development of effective therapies…
Series Unknown ·
$2.8M
I
Palo Alto, United States · Biotechnology
Using a combination of extensive experimental testing and advanced deep learning techniques, Inceptive…
Series A ·
$100M
M
Palo Alto, United States · Biotechnology
The purpose of MapLight Therapeutics is to create and advance treatments for brain disorders through their…
Series Unknown ·
$50M
N
Palo Alto, United States · Biotechnology
Neuvivo is a private, late-clinical stage biopharmaceutical company committed to creating and delivering…
Series Unknown ·
$11M
G
Palo Alto, United States · Biotechnology
modernising musculoskeletal disease treatment
Series Unknown ·
$12M
I
Palo Alto, United States · Biotechnology
A recently founded biopharmaceutical business called Immune-Onc Therapeutics focuses on creating novel…
Series B ·
$25M
C
Palo Alto, United States · Biotechnology
A pediatric behavioral health business called Cognoa is creating digital diagnostics and therapies to help…
Series B ·
$73M
P
Palo Alto, United States · Biotechnology
Pheast Therapeutics is a cancer immunotherapy company focused on developing novel checkpoint therapies to…
Series A ·
$76M
A
Palo Alto, United States · Biotechnology
Ascendis Pharma has built a high value pipeline with the aim of changing clinical treatment paradigms. Using…
Post-IPO Debt ·
$500M
L
Palo Alto, United States · Biotechnology
Limbix is a prescription digital therapeutic company passionate about creating mental health treatments for…
Series A ·
$15M
A
Palo Alto, United States · Biotechnology
Artificial is a software company that develops a lab automation platform. It empowers every lab to realize…
·
$22M

Funding stages of funded Biotechnology startups in Palo Alto

How the last 24 months of funding rounds for funded Biotechnology startups in Palo Alto break down by stage.

Stage
Rounds, last 24 months

A further 11 rounds in this period were announced without a stage label and are not ranked above.

About the FundedIQ Biotechnology startup funding data in Palo Alto

FundedIQ tracks announced startup funding rounds and organises them by company, funding date, stage, amount, industry, location and investor. The dataset is refreshed weekly, and new rounds are normalised and de-duplicated before they are published, so the same round reported twice on different dates is recorded once.

Figures on this page cover the 31 funded Biotechnology startups in Palo Alto currently tracked. Round counts, capital totals and the median round are computed over a trailing 24 months. Rounds whose amount was not disclosed (3 of 18 in that period) are counted as rounds but excluded from capital totals and from the median. The most recent round on record for funded Biotechnology startups in Palo Alto is dated Jun 2026.

The table above shows the 31 most recently funded companies. Full funding histories, investor lists and founder contacts across the whole dataset open on a FundedIQ plan.

Frequently asked questions

How many funded Biotechnology startups are there in Palo Alto?

FundedIQ tracks 31 funded Biotechnology startups in Palo Alto. This page lists the 31 most recently funded of them, ordered by the date of their latest round, and the full set is available on a FundedIQ plan.

How much funding have Biotechnology startups in Palo Alto raised?

Biotechnology startups in Palo Alto tracked by FundedIQ have raised $1.2B in disclosed capital across 18 funding rounds over the last 24 months, including 9 rounds in the last 12 months. 15 of those 18 rounds disclosed an amount; undisclosed rounds are excluded from the capital total.

What is a typical funding round size for Biotechnology startups in Palo Alto?

The median disclosed round over the last 24 months is $26M, and the middle half of rounds fall between $8.0M and $43M. Round sizes vary widely by stage, so the seed and later-stage bands sit well either side of that figure.

What is the most common funding stage for Biotechnology startups in Palo Alto?

Series A is the most common labelled stage, with 3 rounds in the last 24 months, ahead of Seed (2) and Series B (1). A further 11 rounds were announced without a stage label and are not counted here.

How often is the Biotechnology startup funding data in Palo Alto updated?

The dataset is refreshed weekly. New rounds are normalised and de-duplicated before they are published, and the most recent round currently on record for funded Biotechnology startups in Palo Alto is dated Jun 2026. Counts and totals on this page are recomputed on every refresh.

Related listings

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.